Source map — Retraction of high-profile paper on cancer drug timing could hand ammo to China hawks
Every domain this feed has drawn corroborated signal from. We store facts and short excerpts and link back to originals — never republished article bodies.
| Source | Type | Trust |
|---|---|---|
| Fierce Pharma | news | 60% |
| Oncodaily | news | 60% |
| MedPage Today | news | 60% |
| Endpoints News | news | 60% |
| 747 Live | news | 60% |
| The New York Times | news | 60% |
| Applied Clinical Trials Online | news | 60% |
| mezha.net | news | 60% |
| 매일경제 | news | 60% |
| CTV News | news | 60% |
| www.nature.com | news | 50% |
| www.nwcast.com | news | 50% |
| catalystalert.io | news | 50% |
| retractionwatch.com | news | 50% |
| www.breakouttools.com | news | 50% |
| pubmed.ncbi.nlm.nih.gov | gov | 50% |